Release Date: 08/06/22 08:21 Summary: Results of Meeting Price Sensitive: No Download Document 201.17KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans